Fextin-M
FEXTIN-M combines two active ingredients—fexofenadine, a non-sedating antihistamine, and montelukast, a leukotriene receptor antagonist—to provide comprehensive relief for allergic conditions. This combination targets both histamine release and leukotriene pathways, addressing multiple aspects of allergic reactions such as inflammation, congestion, sneezing, and itching.
- Recommended Usage
Indication
- Seasonal allergic rhinitis (hay fever)
- Perennial allergic rhinitis
- Chronic idiopathic urticaria (hives)
- Asthma (as an adjunct treatment)
Dosage and Administration
Route of Administration: Oral tablet, taken once daily.
Typical dose for adults and children over 15 years: 1 tablet (120 mg fexofenadine, 10 mg montelukast) once daily.
Elderly and patients with renal or hepatic impairment: Consult a healthcare provider for appropriate dosage adjustments.
Precautions
Avoid in patients with known hypersensitivity to fexofenadine, montelukast, or any other component of the tablet.
Use caution in patients with liver or kidney impairment.
Not recommended during breastfeeding without consulting a healthcare provider.
May interact with other medications, especially those affecting the liver or metabolism.
Contraindications
Hypersensitivity to fexofenadine, montelukast, or any excipient of the product.
Key Benefits
Dual Action: Combines fexofenadine and montelukast to address both histamine and leukotriene pathways, providing comprehensive allergy relief.
Effective for Multiple Conditions: Useful for both allergic rhinitis and asthma management.
Non-Sedative: Fexofenadine ensures minimal drowsiness, allowing for daytime use.
Convenient Dosage: One tablet daily for simplicity and effectiveness.
Improved Quality of Life: Helps control allergy and asthma symptoms, improving daily functioning and comfort.
